Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06203106 · ClinicalTrials.gov registry record
NYSCF Scientific Discovery Biobank
A clinical trial of Alzheimer Disease and Dementia, sponsored by New York Stem Cell Foundation Research Institute.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT06203106: Recruiting study of Alzheimer Disease and Dementia, sponsored by New York Stem Cell Foundation Research Institute.
NCT06203106 is a study of Alzheimer Disease and Dementia that is actively recruiting participants, run by New York Stem Cell Foundation Research Institute. The registered enrollment target is 10,000 participants, above the 2,718-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (268% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06203106, a study of Alzheimer Disease and Dementia, is actively recruiting participants, sponsored by New York Stem Cell Foundation Research Institute.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and store the samples for future use. Through this research, researchers hope to identify future treatments or even cures for the major diseases of our time.
Primary Outcome
Establishment of a diverse repository of biological samples, stem cell lines, derivatives, and associated information to support investigations into the biology, etiology, manifestations, progression, risk factors, genetic underpinnings, and treatment of diseases, conditions, and traits.
Conditions Studied
Interventions
- OTHER Biological Sample Collection
Study Locations (1)
New York
- New York Stem Cell Foundation Research Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2022-11-10 |
| Est. Completion | 2045-11-10 |
What NCT06203106 shows while recruiting
NCT06203106 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,718-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (268% higher).
The record links to 10 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Biological Sample Collection is the first listed.
NCT06203106 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06203106 about?
NCT06203106 is a clinical study titled "NYSCF Scientific Discovery Biobank". The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and store the...
What is the current status of trial NCT06203106?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2022-11-10. Estimated completion is 2045-11-10.
What conditions does trial NCT06203106 study?
This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Amyotrophic Lateral Sclerosis, Huntington Disease, Frontotemporal Dementia.
What interventions are being tested in trial NCT06203106?
The interventions under investigation include: Biological Sample Collection (OTHER).
Who is sponsoring clinical trial NCT06203106?
This trial is sponsored by New York Stem Cell Foundation Research Institute, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06203106 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06203106's enrollment target sits among peer trials
10,000 10th of 306 higher than 294 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)
RECRUITING · Phase 3
-
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
RECRUITING · Phase 4
-
Systemic and Central Inflammation in AD
RECRUITING · Phase 2
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
RECRUITING · Phase 1
-
Cognitive Neurology Unit Clinical Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI